Popular Articles

Oncothyreon Announces Initiation Of Phase 3 Trial Of Stimuvax In Breast Cancer
Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY) (the "Company") announced that Merck KGaA of Darmstadt, Germany, has initiated a global Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine, L-BLP25) in patients with hormone receptor-positive, locally advanced, recurrent or metastatic breast cancer. Stimuvax is an investigational therapeutic cancer vaccine being developed by Merck KGaA under a license agreement with Oncothyreon.
generic viagra online
Low Birth Weight May Mean Higher Risk For Kidney Disease
Parents of newborns who tip the scales at less than 5 ÷½ pounds should put some heavy thought to a possible future consequence: kidney disease. Low birth weight babies have a 70% greater risk of developing chronic kidney disease (CKD) in later life, according to research published in the August issue of the American Journal of Kidney Diseases, the official journal of the National Kidney Foundation.
News of the day
Study Suggests Vitamin D Screening And Appropriate Supplementation Indicated For All Cancer Patients
Vitamin D deficiency was found to be prevalent in cancer patients regardless of nutritional status, according to the results of a recent study conducted at Cancer Treatment Centers of America (CTCA). Based on these results, CTCA researchers determined that screening for vitamin D deficiency and aggressive vitamin D repletion should be considered for all people with cancer.
Cardiovascular

HANYS Calls On Legislature To Pass Measure To Help Families Prevent Health Care Decision Nightmares

The Healthcare Association of New York State (HANYS) called on the State Legislature to pass much-needed legislation that will better protect the rights of incapacitated patients and spare family members from the nightmare of helplessly watching their loved one"s health care wishes go unfulfilled. New York is one of only two states in the nation that bars family members from making treatment decisions for incapacitated patients. Only 25% of New Yorkers have a "health care proxy." Without one, family members are powerless to make health decisions for loved ones. HANYS distributes wallet-sized proxy forms to anyone on request, but more must be done. The legislation, known as the "Family Health Care Decisions Act," allows medical treatment decisions to be made privately by the patient"s family or friends based on common sense standards: the patient"s expressed wishes or, if unknown, the patient"s best interest. Consultation with medical professionals is required to avoid hasty or ill-motivated decisions. Above all else, the legislation would require that all decisions be made out of respect for, and in consideration of, the individual dignity and uniqueness of the patient. "These patients and their families are lost in the loopholes of existing law, too often resulting in terrible, unneeded suffering on the part of the patient and the patient"s loved ones," said HANYS President Daniel Sisto. "We need to free them from these terrible dilemmas and give the patient every opportunity to have his or her own wishes fulfilled. It is an essential right for all of us." The bill is sponsored in the Legislature by Senator Thomas Duane and Assemblyman Richard Gottfried. Healthcare Association of New York State


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):